Abbott India Gets Central Nod For Kartik Rajendran As Managing Director

Abbott India announced that the Central Government has formally approved the appointment of Kartik Rajendran as its Managing Director. The approval, dated November 21, 2025, was communicated to BSE Limited on November 24, 2025. Rajendran’s appointment had earlier been intimated in May and August 2025, and now stands officially ratified under Section 196 of the Companies Act, 2013.  

Key highlights from the announcement include  

• Kartik Rajendran’s appointment as Managing Director is effective from June 14, 2025.  
• His tenure will span five years, concluding on June 13, 2030.  
• The Central Government’s approval provides regulatory clarity and leadership stability.  
• Abbott India had earlier notified exchanges about the proposed appointment in May and August 2025.  
• The decision aligns with statutory requirements under the Companies Act, 2013.  
• Leadership continuity is expected to support Abbott India’s strategic objectives in the healthcare sector.  

This appointment marks a significant step in Abbott India’s governance framework, reinforcing confidence among stakeholders and ensuring stability in its leadership structure for the next five years.  

Sources: InvestyWise, FilingReader, Abbott India Official Filing